Andrew Gengos, CFO AND CHIEF BUSINESS OFFICER at Athira Pharma, Inc. (ATHA), sold 1,208 shares at $2.91 ($4K) on 2024-01-05, disclosed to the SEC on 2024-02-16.
Open-market sale of $4k ATHA by CFO AND CHIEF BUSINESS OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ATHA | SELL | 2024-09-05 | $725 | — | Filing → |
| ATHA | SELL | 2024-01-08 | $4K | — | Filing → |
| ATHA | BUY | 2023-06-09 | $51K | — | Filing → |